Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Intellia Therapeuticsintelliatx.com · Low evidenceIntellia Therapeutics (IntelliaTX) is a biotechnology company developing CRISPR-based gene editing therapies for genetic diseases. It focuses on discovering and advancing in vivo gene editing medicines through internal programs and partnerships. The website uses cookies for operation, analytics, and personalization, and includes a careers portal for talent recruitment.
Parse Score